Dr. Stephen Gomperts is a member of the Clinical Core of the Massachusetts Alzheimer’s Disease Research Center (MADRC) and the director of the Lewy Body Dementia Unit at Massachusetts General Hospital. His translational and clinical research focuses on molecular imaging of and therapeutics for pathological processes that contribute to Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). He is principal investigator a study to image histone deacetylase in PD using a radiolabeled inhibitor as well as on grants evaluating longitudinal PET imaging of brain amyloid and tau in PD, PD dementia and DLB. He is a co-investigator on a funded study evaluating a promising small molecule therapeutic in PD models.